These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 4427418)

  • 21. The alteration of plasma proteins in uremia as reflected in their ability to bind digitoxin and diphenylhydantoin.
    Shoeman DW; Azarnoff DL
    Pharmacology; 1972; 7(3):169-77. PubMed ID: 5054587
    [No Abstract]   [Full Text] [Related]  

  • 22. Impaired plasma protein binding of phenytoin in uremia and displacement effect of salicylic acid.
    Odar-Cederlöf I; Borga O
    Clin Pharmacol Ther; 1976 Jul; 20(1):36-47. PubMed ID: 1277724
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma binding and disposition of furosemide in the nephrotic syndrome and in uremia.
    Rane A; Villeneuve JP; Stone WJ; Nies AS; Wilkinson GR; Branch RA
    Clin Pharmacol Ther; 1978 Aug; 24(2):199-207. PubMed ID: 679597
    [No Abstract]   [Full Text] [Related]  

  • 24. Protein binding of drugs in uremic and normal serum: the role of endogenous binding inhibitors.
    Sjöholm I; Kober A; Odar-Cederlöf I; Borgåa O
    Biochem Pharmacol; 1976 May; 25(10):1205-13. PubMed ID: 938543
    [No Abstract]   [Full Text] [Related]  

  • 25. Plasma protein binding of thiopental in patients with impaired renal or hepatic function.
    Ghoneim MM; Pandya H
    Anesthesiology; 1975 May; 42(5):545-9. PubMed ID: 1130720
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Carbamylated plasma protein in renal failure.
    Oimomi M; Nishimoto S; Matsumoto S; Hatanaka H; Ishikawa K; Kawasaki T; Yoshimura Y; Baba S
    Nihon Jinzo Gakkai Shi; 1986 Mar; 28(3):269-71. PubMed ID: 3723861
    [No Abstract]   [Full Text] [Related]  

  • 27. Testosterone and its binding in the plasma of male subjects with chronic renal failure.
    Gupta D; Bundschu HD
    Clin Chim Acta; 1972 Feb; 36(2):479-84. PubMed ID: 4109468
    [No Abstract]   [Full Text] [Related]  

  • 28. The binding of chloramphenicol to albumin of normal and uremic sera.
    Vodrázka Z; Jandová D; Grafnetterová J; Schück O; Kalousek I; Tomaásek R; Lachmanová J
    Biochem Pharmacol; 1978; 27(13):1717-20. PubMed ID: 708450
    [No Abstract]   [Full Text] [Related]  

  • 29. Effects of uremic toxins and fatty acids on serum protein binding of furosemide: possible mechanism of the binding defect in uremia.
    Takamura N; Maruyama T; Otagiri M
    Clin Chem; 1997 Dec; 43(12):2274-80. PubMed ID: 9439444
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cortisol binding in uremic plasma. II. Decreased cortisol binding to albumin.
    Rosman PM; Benn R; Kay M; Wallace EZ
    Nephron; 1984; 37(4):229-31. PubMed ID: 6462312
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma protein binding of phenytoin and warfarin in patients undergoing renal transplantation.
    Odar-Cederlof I
    Clin Pharmacokinet; 1977; 2(2):147-53. PubMed ID: 324689
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aromatic amino acid metabolites as potential protein binding inhibitors in human uremic plasma.
    Tavares-Almeida I; Gulyassy PF; Depner TA; Jarrard EA
    Biochem Pharmacol; 1985 Jul; 34(14):2431-8. PubMed ID: 4015686
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Evaluation of platelet kinetics in chronic renal failure (conservative and regular dialysis treatment) (author's transl)].
    Lusvarghi E; Curci G; Sacchi S; Baraldi P; Baraldi A; Cappelli G; Landini S; Malmusi G; Orlandini G; Savazzi AM; Vandelli L; Quaglino D
    Haematologica; 1979 Dec; 64(6):747-58. PubMed ID: 121088
    [No Abstract]   [Full Text] [Related]  

  • 34. Decreased drug binding in uraemia: effect of indoxyl sulphate and other endogenous substances on the binding of drugs and dyes to human albumin.
    Bowmer CJ; Lindup WE
    Biochem Pharmacol; 1982 Feb; 31(3):319-23. PubMed ID: 6803808
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma aminothiol oxidation in chronic hemodialysis patients.
    Himmelfarb J; McMenamin E; McMonagle E
    Kidney Int; 2002 Feb; 61(2):705-16. PubMed ID: 11849414
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma tryptophan level in chronic renal failure.
    Cernácek P; Becvárová H; Gerová Z; Válek A; Spustová V
    Clin Nephrol; 1980 Nov; 14(5):246-9. PubMed ID: 7226582
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mass spectrometric monitoring of albumin in uremia.
    Thornalley PJ; Argirova M; Ahmed N; Mann VM; Argirov O; Dawnay A
    Kidney Int; 2000 Nov; 58(5):2228-34. PubMed ID: 11044246
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of trace elements in peritoneal dialysis, hemodialysis, and uremia.
    Thomson NM; Stevens BJ; Humphery TJ; Atkins RC
    Kidney Int; 1983 Jan; 23(1):9-14. PubMed ID: 6834697
    [No Abstract]   [Full Text] [Related]  

  • 39. Effects of acetylsalicylic acid on serum protein binding and metabolism of tryptophan in man.
    Smith HG; Lakatos C
    J Pharm Pharmacol; 1971 Mar; 23(3):180-9. PubMed ID: 4396888
    [No Abstract]   [Full Text] [Related]  

  • 40. Plasma protein carbamylation and decreased acidic drug protein binding in uremia.
    Erill S; Calvo R; Carlos R
    Clin Pharmacol Ther; 1980 May; 27(5):612-8. PubMed ID: 7371359
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.